RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 12, 2006, Pages 5385-5394

  Gregerson, Dale S ^a   Lew, Kathleen L ^a   McPherson, Scott W ^a   Heuss, Neal D ^a   Ferrington, Deborah A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA GALACTOSIDASE; CASPASE 3; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEASOME; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL CULTURE; CELL DESTRUCTION; CELL KILLING; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHAGOCYTE; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; T LYMPHOCYTE; UPREGULATION; ANIMAL; BYSTANDER EFFECT; COCULTURE; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; WESTERN BLOTTING;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; APOPTOSIS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; BYSTANDER EFFECT; CASPASE 3; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; PIGMENT EPITHELIUM OF EYE; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248215643     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0636     Document Type: Article

References (47)

1. Adamus G, Chan CC. Experimental autoimmune uveitides: multiple antigens, diverse diseases. Int Rev Immunol. 2002;21:209-229.
2. McPherson SW, Heuss ND, Roehrich H, Gregerson DS. Bystander killing of neurons by cytotoxic T cells specific for a glial antigen. Glia. 2006;53:457-466.
3. Gregerson DS, Torseth JW, McPherson SW, Roberts JP, Shinohara T, Zack DJ. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic, and creates a target for autoimmune uveoretinitis. J Immunol. 1999;163:1073-1080.
4. Gregerson DS, Dou C. Spontaneous induction of immunoregulation by an endogenous retinal protein. Invest Ophthalmol Vis Sci. 2002;43:2984-2991.
5. Ham DI, Kim SJ, Chen J, et al. Central immunotolerance in transgenic mice expressing a foreign antigen under control of the rhodopsin promoter. Invest Ophthalmol Vis Sci. 2004;45:857-862.
6. Anderson MS, Venanzi ES, Klein L, et al. Projection of an immunological self-shadow within the thymus by the aire protein. Science. 2002;298;1395-1401.
7. Avichezer D, Grajewski RS, Chan CC, et al. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J Exp Med. 203;198:1665-1676.
8. McPherson SW, Yang J, Chan CC, Dou C, Gregerson DS. Resting CD8 T cells recognize beta-galactosidase expressed in the immune privileged retina, and mediate autoimmune disease when activated. Immunology. 2003;110:386-396.
9. Matzinger P. The danger model: a renewed sense of self. Science. 2002;296:301-305.
10. Vezys V, Lefrancois L. Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J Immunol. 2002;169:6677-6680.
11. Ferrington DA, Tran TN, Lew KL, Van Remmen H, Gregerson DS. Different death stimuli evoke apoptosis via multiple pathways in retinal pigment epithelial cells. Exp Eye Res. 2006;83:638-650.
12. Bradshaw JJ, Obritsch WF, Cho BJ, Gregerson DS, Holland EJ. Ex vivo transduction of corneal epithelial progenitor cells using a retroviral vector. Invest Ophthalmol Vis Sci. 1999;40:230-235.
13. Molday RS, Hicks D, Molday L. Peripherin. A rim-specific membrane protein of rod outer segment discs. Invest Ophthalmol Vis Sci. 1987;28:50-61.
14. Kapphahn RJ, Giwa BM, Berg KM, et al. Retinal proteins modified by 4-hydroxynonenal: identification of molecular targets. Exp Eye Res. 2006;83:165-175.
15. Gavin MA, Gilbert MJ, Riddell SR, Greenberg PD, Bevan MJ. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol. 1993,151:3971-3980.
16. Dick LR, Aldrich C, Jameson SC, et al. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J Immunol. 1994;152:3884-3894.
17. Bennink JR, Yewdell JW. Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Curr Topics Microbiol Immunol. 1990;163:153-184.
18. Louie J, Kapphahn R, Ferrington DA. Proteasome function and protein oxidation in the aged retina. Exp Eye Res. 2002;75:271-284.
19. Jerome KR, Sloan DD, Aubert M. Measurement of CTL-induced cytotoxicity: the caspase 3 assay. Apoptosis. 2003;8:563-571.
20. York I, Rock KL. Presentation of antigens on MHC class I molecules. Ann Rev Immunol. 1996;14:369-396.
21. Macagno A, Gilliet M, Sallusto F, Lanzavecchia A, Nestle FO, Groettrup M. Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur J Immunol. 1999;29:4037-4042.
22. Kaestel CG, Jorgensen A, Nielsen M, et al. Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells. Exp Eye Res. 2002;74:627-637.
23. Liversidge J, McKay D, Mullen G, Forrester JV. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol. 1993;149:315-330.
24. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol. 1997;15:821-850.
25. Rezai KA, Semnani RT, Farrokh-Siar L, et al. Human fetal retinal pigment epithelial cells induce apoptosis in allogenic T-cells in a Fas ligand and PGE2 independent pathway. Curr Eye Res. 1999;18:430-439.
26. Farrokh-Siar L, Rezai KA, Semnani RT, et al. Human fetal retinal pigment epithelial cells induce apoptosis in the T-cell line Jurkat. Invest Ophthalmol Vis Sci. 1999;40:1503-1511.
27. Farrokh-Siar L, Rezai KA, Palmer EM, Patel SC, Ernest JT, van Seventer GA. Human fetal retinal pigment epithelium-induced cell cycle arrest, loss of mitochondrial membrane potential and apoptosis. Invest Ophthalmol Vis Sci. 2000;41:3991-3998.
28. Jorgensen A, Wiencke AK, la Cour M, et al. Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci. 1998;39:1590-1599.
29. Rezai KA, Farrokh-Siar L, Gasyna EM, Ernest JT, van Seventer GA. The effect of type I and II interferons on human fetal retinal pigment epithelium-induced apoptosis in Jurkat T cells. Invest Ophthalmol Vis Sci. 2003;44:3130-3134.
30. Willermain F, Caspers-Velu L, Nowak B, et al. Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eye. Br J Ophthalmol. 2002;86:1417-1421.
31. Kaestel CG, Lovato P, Odum N, Nissen MH, Ropke C. The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation in vitro. Curr Eye Res. 2005;30:375-383.
32. Sugita S, Streilein JW. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2003;198:161-171.
33. Zamiri P, Zhang Q, Streilein JW. Vulnerability of allogeneic retinal pigment epithelium to immune T-cell-mediated damage in vivo and in vitro. Invest Ophthalmol Vis Sci. 2004;45:177-184.
34. Rock KL, York IA, Saric T, Goldberg AL. Protein degradation and the generation of MHC class I-presented peptides. Adv Immunol. 2002;80:1-70.
35. Chen W, Norbury CC, Cho Y, Yewdell JW, Bennink JR. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J Exp Med. 2001;193:1319-1326.
36. van Hall T, Sijts A, Camps M, et al. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28. J Exp Med. 2000;192:483-494.
37. Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature. 2003;425:397-402.
38. Houde M, Bertholet S, Gagnon E, et al. Phagosomes are competent organelles for antigen cross-presentation. Nature. 2003;425:402-406.
39. Touret N, Paroutis P, Terebiznik M, et al. Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell. 2005;123:157-170.
40. Wang Y, Detrick B, Yu ZX, Zhang J, Chesky L, Hooks JJ. The role of apoptosis within the retina of coronavirus-infected mice. Invest Ophthalmol Vis Sci. 2000;41:3011-3018.
41. Kaestel CG, Madsen HO, Prause JU, et al. Lack of FasL expression in cultured human retinal pigment epithelial cells. Exp Clin Immunogenet. 2001;18:34-41.
42. Kanuga N, Winton HL, Beauchene L, et al. Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies. Invest Ophthalmol Vis Sci. 2002;43:546-555.
43. Esser P, Heimann K, Abts H, Fontana A, Weller M. CD95 (Fas/APO-1) antibody-mediated apoptosis of human retinal pigment epithelial cells. Biochem Biophys Res Commun. 1995;213:1026-1034.
44. Jiang S, Wu MW, Sternberg P, Jones DP. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells. Invest Ophthalmol Vis Sci. 2000;41:645-655.
45. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19:205-221.
46. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA. 2004;101:8491-8496.
47. Strunnikova N, Zhang C, Teichberg D, et al. Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis. Invest Ophthalmol Vis Sci. 2004;45:3767-3777.